Todd S. Young - Mar 3, 2025 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
Executive Vice President and Chief Financial Officer
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for Todd S. Young
Stock symbol
ELAN
Transactions as of
Mar 3, 2025
Transactions value $
$0
Form type
4
Date filed
3/5/2025, 06:50 PM
Previous filing
Mar 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Award $0 +64.1K +46.84% $0.00 201K Mar 3, 2025 Direct F1
holding ELAN Common Stock 6.56K Mar 3, 2025 By IRA
holding ELAN Common Stock 2K Mar 3, 2025 By J. G. Young IRA
holding ELAN Common Stock 5.5K Mar 3, 2025 As UTMA custodian for daughter
holding ELAN Common Stock 5.5K Mar 3, 2025 As UTMA custodian for son
holding ELAN Common Stock 149K Mar 3, 2025 By Living Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELAN Employee Stock Option (right to buy) Award $0 +135K $0.00 135K Mar 3, 2025 Common Stock 135K $11.31 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units vesting as follows: one-third vesting on March 3, 2026, one-third vesting on March 3, 2027, and the remaining vesting on March 3, 2028.
F2 Grant of stock options vesting as follows: one-third vesting on March 3, 2026, one-third vesting on March 3, 2027, and the remaining vesting on March 3, 2028.

Remarks:

Executive Vice President and Chief Financial Officer